Application Value of Laparoscopic Roux-en-Y Gastric Bypass in Improving the Quality of Life for Obese Patients

Wu Fangxu,Chen Xi,Chen Wei,Zhang Jingjing,Zhou Zhiguang,Liu Wei

DOI: https://doi.org/10.3877//cma.j.issn.2095-9605.2016.02.007

2016-01-01

Abstract:Objective To investigate the application value of laparoscopicRoux-en-Y gastric bypass (LRYGB) in improving the quality of life for obese patients and to analyze the factors related to the quality of life before and after LRYGB.Methods Clinical data of 20 obese patients undergoing LRYGB in the Second Xiangya Hospital of Central South University from February 2013 to February 2014 were analyzed retrospectively. The informed consents were obtained from all of the patients and the local ethical committee approval had been received. Among the 20 patients, 10 were males and 10 were females with an average age of (43±3) years old. The data of weight, body mass index (BMI), percentage of excess body weight loss (EWL%), fasting plasma glucose (FPG) and glycosylated hemoglobin A1c (HbA1c) were measured pre-and post-operatively, the improvement of complications was also recorded. The Moorhead-Ardelt Quality of Life QuestionnaireⅡ(MAⅡ) was used to evaluate the quality of life. The comparisons of clinical indexes before and after operation were conducted using pairedt test, the comparison of the rank of quality of life was conducted using Spearman rank correlation analysis, and the correlation analysis between quality of life and BMI, FPG and HbA1c was conducted using Pearson correlation analysis.Results Twenty patients received LRYGB successfully. One patient with anastomotic leakage and another one with pneumonia after operation were cured with conservative treatments. At 12 months after operation, BMI was (27.7±0.9) kg/m2, which was significantly lower than (37.5±1.8) kg/m2 before operation (t=9.47,P<0.05); FPG was (5.24±0.11) mmol/L, significantly lower than (7.91±0.60) mmol/L before operation (t=4.52,P<0.05); HbA1c was (5.60±0.11)%, significantly lower than (8.65±0.56)% before operation (t=5.53,P<0.05); and the total score of life quality was 1.33±0.16, which was also significantly higher than-0.07±0.24 before operation (t=-5.09,P<0.05). The correlation analysis showed that BMI was negatively correlated with the total score of life quality preoperatively (r=-0.45,P<0.05), while FPG was negatively correlated with the total score of life quality postoperatively (r=-0.54,P<0.05).Conclusions LRYGB is a safe and effective therapeutic method for obesity and type 2 diabetes, which can improve patients’ quality of life postoperatively. There are relevant relationships between BMI, FPG and pre- and post-operative quality of life, suggesting that BMI and FPG should be predicted and evaluated as outcome analysis of LRYGB.